| Literature DB >> 35475084 |
Eustáquio C Santos Júnior1, François Dantas1, Antônio Carlos V Caires1, Gustavo A Cariri1, Marco Túlio D Reis1, Ricardo V Botelho2, Fernando Luiz R Dantas1.
Abstract
BACKGROUND: Primary spinal cord tumors are rare and heterogeneous, and their prevalence varies among the studies. Few articles have evaluated the prevalence, characteristics, and histological types of spinal cord tumors in Latin American populations. This study aimed to analyze the histological types and clinical aspects of a series of consecutive patients diagnosed with primary spinal cord tumors who underwent surgical treatment in a single Brazilian institution and to compare them with the literature.Entities:
Keywords: epidemiology; extradural; extramedullary; intradural; intramedullary; spinal cord; spine; tumor
Year: 2022 PMID: 35475084 PMCID: PMC9023327 DOI: 10.7759/cureus.23408
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographics, surgical characteristics, and clinical features
| n (N=104) | Percentage | |
| Sex | ||
| Female | 53 | 51.0% |
| Male | 51 | 49.0% |
| Age (years) | ||
| 18-20 | 2 | 1.92% |
| 21-40 | 34 | 32.7% |
| 41-60 | 38 | 36.5% |
| >60 | 30 | 28.8% |
| Benign/Malignant | ||
| Benign | 87 | 83.7% |
| Malignant | 17 | 16.3% |
| Spinal segment | ||
| Thoracic | 38 | 36.5% |
| Lumbar | 25 | 24.0% |
| Cervical | 23 | 22.1% |
| Lumbosacral | 11 | 10.6% |
| Cervicothoracic | 4 | 3.8% |
| Thoracolumbar | 3 | 2.9% |
| Spinal compartment | ||
| Intradural extramedullary | 55 | 52.9% |
| Intramedullary | 24 | 23.1% |
| Extradural | 18 | 17.3% |
| Dumbbell | 7 | 6.7% |
| n (N=100) | Percentage | |
| Presentation | ||
| Pain | 55 | 55.0% |
| Motor deficit | 50 | 50.0% |
| Sensory deficit | 27 | 27.0% |
| Sphincter disorders | 18 | 18.0% |
Primary spinal cord tumors based on pathology
| Type of tumor | N | Percentage |
| Schwannoma | 28 | 26.9% |
| Meningioma | 19 | 18.3% |
| Ependymoma | 14 | 13.5% |
| Astrocytoma | 6 | 5.8% |
| Hemangioblastoma | 6 | 5.8% |
| Sarcoma | 4 | 3.8% |
| Cavernoma | 3 | 2.9% |
| Arachnoid cyst | 2 | 1.9% |
| Ganglioneuroma | 2 | 1.9% |
| Neurofibroma | 2 | 1.9% |
| Malignant peripheral nerve sheet tumor | 2 | 1.9% |
| Others | 16 | 15.4% |
Comparison between neurological status at admission and at discharge
| Neurological status at admission | n (N=74) (%) | Neurological status at discharge | ||||
| New deficit | Unchanged | Improvement | Worsening | |||
| Motor deficit | Present | 38 (51.4%) | 0 (0%) | 19 (25.7%) | 13 (17.6%) | 6 (8.1%) |
| Absent | 36 (48.6%) | 4 (5.4%) | 32 (43.2%) | 0 (0%) | 0 (0%) | |
| Sensory deficit | Present | 25 (33.8%) | 0 (0%) | 17 (23%) | 8 (10.8%) | 0 (0%) |
| Absent | 49 (66.2%) | 4 (5.4%) | 45 (60.8%) | 0 (0%) | 0 (0%) | |
| Pain | Present | 37 (50%) | 0 (0%) | 8 (10.8%) | 29 (39.2%) | 0 (0%) |
| Absent | 37 (50%) | 0 (0%) | 37 (50%) | 0 (0%) | 0 (0%) | |
| Sphincter disorders | Present | 13 (17.6%) | 0 (0%) | 8 (10.8%) | 5 (6.8%) | 0 (0%) |
| Absent | 61 (82.4%) | 1 (1.4%) | 60 (81.1%) | 0 (0%) | 0 (0%) | |
Case series and data-base studies of primary spinal cord tumors
Abbreviations: IDEM, intradural extramedullary; IMSCT, intramedullary spinal cord tumor; N/A, not available
*Case series that included only intradural extramedullary tumors
+Case series that included only intramedullary tumors
| Author & Year | Country | Year | N | % IDEM (most common) | % IMSCT (most common) | Female/Male | Mean age (years) |
| Preston-Martin, 1990 [ | USA | 1972–1985 | 462 | N/A | N/A | 59.5%/40.5% | N/A |
| Hufana et al., 2005[ | Singapore | 1992–2002 | 93 | 79.6% (schwannoma) | 9.7% (astrocytoma / ependymoma) | 52.7%/47.3% | 49.0 |
| Gelabert-González, 2007 [ | Spain | 1980–2004 | 168 | 66.1% (meningioma) | 33.9% (ependymoma) | 58.3%/41.7% | N/A |
| Schellinger et al., 2008 [ | USA | 1998–2002 | 3,226 | N/A | N/A | 55%/45% | 51.0 |
| Alpízar-Aguirre et al., 2009 [ | Mexico | 1996–2006 | 27 | 100% (schwannoma / meningioma) | 0% | 40.7%/59.3% | 47.3 |
| Engelhard et al., 2010 [ | USA | 2000 | 430 | N/A | N/A | 56.7%/43.3% | 49.3 |
| Hirano et al., 2012 [ | Japan | 2000–2009 | 678 | 54.7% (schwannoma) | 18.1% (ependymoma) | 44.4%/55.6% | 52.4 |
| Duong et al., 2012 [ | USA | 1999–2007 | 11,712 | N/A | N/A | 59.1%/40.9% | N/A |
| Ozawa et al., 2013 [ | Japan | 2008–2010 | 112 | 53.0% (schwannoma) | 18.0% (ependymoma) | 46%/54% | 55.0 |
| Moein et al., 2013 [ | Iran | 1992–2004 | 102 | 45.1% (schwannoma) | 35.3% (ependymoma) | 42.2/57.8% | 40.2 |
| Bansal et al., 2013 [ | India | 2001–2010 | 195 | 0% | 100% (ependymoma) | 29.7%/70.2% | 26.0 |
| Zhixu Ng et al., 2018 [ | Singapore | 2011–2016 | 91 | 89.0% (schwannoma) | 11.0% (ependymoma) | 40.7%/59.3% | 46.0 |
| Guerrero-Suarez et al., 2018 [ | Mexico | 2006–2016 | 35 | 85.7% (schwannoma) | 14.3% (ependymoma) | 25.7%/74.3% | 43.0 |
| Ouma, 2019 [ | South Africa | 2014–2017 | 92 | 100% (schwannoma) | 0% | 38.3%/61.7% | N/A |
| Singuepire et al., 2019 [ | Cuba | 2008–2013 | 31 | 42% (N/A) | 9.6% (N/A) | 54.8%/45.2% | 54.4 |
| Tsai et al., 2020 [ | Taiwan | 2004–2014 | 247 | N/A | N/A | 50.2%/49.8% | 55.4 |
| Brazilian series | |||||||
| Ferreira et al., 1981 [ | Brazil | 1973–1980 | 100 | N/A | N/A | 48%/57% | N/A |
| Koerbel et al., 2002 [ | Brazil | 1993–1999 | 35 | 0% | 100% (ependymoma) | 32.4%/68.6% | 32.9 |
| Prevedello et al., 2003 [ | Brazil | 1993–1999 | 44 | 100% (schwannoma) | 0% | 43.2%/56.8% | 32.9 |
| Taricco et al., 2008[ | Brazil | 1992–2005 | 48 | 0% | 100% (ependymoma) | 40%/60% | 35.0 |
| Present series | Brazil | 1997–2021 | 104 | 52.9% (schwannoma) | 23.1% (ependymoma) | 51%/49% | 49.0 |